Skip to main content

Vasculitis

      🤵‍♂️Results from BACHELOR

      ➡️34 PMR pts
      ➡️18 BARI, 16 PBO
      ➡️Primary endpoint: CRP PMR-AS≤10 w/o o
      1 month ago
      🤵‍♂️Results from BACHELOR ➡️34 PMR pts ➡️18 BARI, 16 PBO ➡️Primary endpoint: CRP PMR-AS≤10 w/o oral GC rescue from W0 to 12 78% BARI pts reached primary endpoint vs 13% PBO No new safety signals BARI 4mg 12W, then 2mg 12W➡️36W low disease activity in PMR Ab0858 #ACR24 @RheumNow
      Systematic review suggests (although not provn) that audiovestibular dysfunction may be from APS. Anti-phospholipid &amp
      1 month ago
      Systematic review suggests (although not provn) that audiovestibular dysfunction may be from APS. Anti-phospholipid & HSP-70 Abs found 25-33% w/idiopathic sudden sensorineural hearing loss,. ACL Abs seen in up to 27% w/ sensorineural hearing loss https://t.co/WcmeCP0ryq https://t.co/DiYX57R0uG
      Results from MANDARA- #EGPA pts treated with benralizumab or mepolizumab

      Eosinophil-targeting biologics rapidly control
      1 month ago
      Results from MANDARA- #EGPA pts treated with benralizumab or mepolizumab Eosinophil-targeting biologics rapidly control airway- & non-airway-related manifestations Few pts had worsening of disease that progressed to organ damage over 52W Ab0828 #ACR24 @RheumNow https://t.co/hIn9iyNVWQ
      Clinicians treating giant cell arteritis (GCA) have long had to contend with a disappointingly limited selection of drugs from which to select. Glucocorticoids were until relatively recently our sole…
      This abstract reports that patients with ESRD 2/2 to GPA have a higher risk of vertebral fractures compared to individua
      This abstract reports that patients with ESRD 2/2 to GPA have a higher risk of vertebral fractures compared to individuals with ESRD without GPA. Even low dose steroids (pred 5mg) taken during the first year of HD conferred an increase risk or facture! #ACR24 @RheumNow https://t.co/4xM3XTCHSH
      Harkins @DrTrishHarkins et al. People with PMR exhibit an accelerated physical aging phenotype at baseline. High rates o
      Harkins @DrTrishHarkins et al. People with PMR exhibit an accelerated physical aging phenotype at baseline. High rates of frailty (41%), pre-frailty (28%), cognitive impairment (74%!), sarcopenia (23%), osteoporosis (21%) @RheumNow #ACR24 Abstr#0740 https://t.co/4ZT8VtGi1W https://t.co/xBQ5CLlb5A
      ×